grant
Estimating population size and health indicators for people who inject drugs in U.S. cities
NIHUS FederalResearch GrantFY2026AIDS VirusAccelerationAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAdvocateAgeAge DistributionBehaviorBehavioralCharacteristicsCitiesCollaborationsCommunicable DiseasesDataDecision MakingDiagnosisDrug userDrugsEpidemiologyEvaluationFutureGeneralized GrowthGeographyGroups at riskGrowthHCVHCV infectionHCV/HIVHIVHIV InfectionsHIV and HCVHIV and hepatitis CHIV diagnosisHIV viral infectionHIV virus infectionHIV-1 infectionHIV-HCVHIV/HCVHIV/Hepatitis CHealthHealth ServicesHepatitis C virusHepatitis C virus infectionHuman Immunodeficiency VirusesHybridsInfection by HIV-1Infection from HIV-1Infection of HIV-1Infectious DiseasesInfectious DisorderInjecting drug userInjection Drug UserInjectionsInterventionIntervention StrategiesLAV-HTLV-IIILocationLymphadenopathy-Associated VirusMapsMeasuresMedicalMedicationMeta-AnalysisMethodologyMethodsModelingMonitorNeedle SharingNeedle-Exchange ProgramsOlder PopulationOutcomeOverdosePWIDPWUDPeople at riskPersonsPersons at riskPharmaceutical PreparationsPolicy MakerPopulationPopulation CharacteristicsPopulation DensityPopulation DistributionsPopulation InterventionPopulation SizesPopulations at RiskPrevalencePublic HealthPublishingResearchResearch ResourcesResource AllocationResource SharingResourcesRiskRisk FactorsRisk ReductionRouteServicesStandardizationStigmatizationStructureSubstance Use DisorderSyringe SharingSyringe-Exchange ProgramsSyringesTimeTissue GrowthUpdateVirus-HIVWorkadverse consequenceadverse outcomeage associatedage correlatedage dependentage groupage linkedage relatedage specificagedagesdata resourcedrug/agenteffective interventionepidemiologicepidemiologicalexperiencehepatitis C infectionhigh riskhuman immunodeficiency virus infectionimplementation interventionimprovedinfected with HCVinfected with HIVinfected with hepatitis Cinfected with hepatitis C virusinfected with human immunodeficiency virusinfection by hepatitis c virusinfection with HCVinfection with hepatitis Cinfection with hepatitis C virusinjection drug useinterestintervention designneedle exchangenovelolder groupsolder individualsolder personontogenyopiate crisisopioid crisisopioid epidemicoverdose deathoverdose fatalitiesoverdose riskpeople who inject drugspeople who inject illicit drugspeople who use drugspeople who use illicit drugspersons who inject drugspersons who use drugspopulation based interventionpopulation healthpopulation specific interventionpreventpreventingprevention serviceprogramspublic health interventionreduce riskreduce risksreduce that riskreduce the riskreduce these risksreduces riskreduces the riskreducing riskreducing the riskresponserisk-reducingservice deliverysubstance usesubstance use and disordersubstance usingsurveillance datasyringe exchangesyringe exchange servicessyringe service programssyringe servicestherapy designtreatment designtreatment services
Description preview
PROJECT ABSTRACT
Substance use via injection carries very high risk for overdose, HIV, and hepatitis C virus (HCV) infection.
Injection drug use (IDU) is highly stigmatized and criminalized in the U.S., making health information difficult to
collect from people who inject drugs (PWID). PWID population size estimates (PSEs) are needed for use as…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click